# VALIDATION — Product Vision Alignment

- **Workstream:** `dispatch/workstreams/product-vision-alignment`
- **Branch:** `feature/product-vision-alignment`
- **Task under validation:** TASK-1 — Product-context edits
- **Recovery task:** separate re-invocation after prior tester cancellation (no prior receipt; full revalidation performed)
- **Mode:** Documentation-only; no code, roadmap, commercial infrastructure, or alignment audit.
- **Reading receipts:** PLAN.md, ARCHITECTURE.md, EXPLORATION.md, READY.md, TASK-1.md, `context/product/vision.md`, `context/product/product-principles.md`, `context/architecture/architecture.md`, `context/roadmap/roadmap.md`.

## Scope boundary

Verified via `git status --porcelain` + `git diff`: within `context/`, only the three prescribed files changed for this workstream — `context/product/vision.md`, `context/product/product-principles.md`, `context/architecture/architecture.md` (`3 files changed, 9 insertions(+), 5 deletions(-)`). `context/roadmap/roadmap.md` and all `context/features/*` are unchanged (roadmap `git status` empty; no feature file in modified list). `context/architecture/database.md` change predates this workstream (Phase 5), confirmed out of scope. No application code, schema, dependency, or configuration file is attributable to this task.

## Check results

### 1. Requested lifecycle — PASS
- Canonical **Build → Experiment → PAPER → LIVE → Monitor → Improve** is the authoritative home in `vision.md` (What Atlas Is, line 5) and the Success statement (line 37).
- `product-principles.md:5` references it via direct relative link `(vision.md)` — no second long-form copy.
- `architecture.md:5` directly references `[Vision](../product/vision.md)` and **restates neither lifecycle phrase** (grep of the full phrase across `context/` hits only `vision.md` + `product-principles.md`).
- **No legacy `Build → Test → Deploy → Monitor → Improve` / `test → deploy` lifecycle text remains** in `context/`. The sole `Test.*Deploy` match in `architecture.md:21` is the backend stack sentence ("...by responsibility, not by deployable service") — unrelated to lifecycle. `test → deploy` lowercase in Success was removed (diff confirms).
- Single authoritative home per decision upheld: lifecycle lives in full only in `vision.md`.

### 2. Proprietary / licensed / local-first safety — PASS
- `vision.md:5` states direction declaratively: "intended as a proprietary, licensed, local-first product: the application, runtime, and durable product state operate under the customer's control, with broker and market-data integrations remaining external dependencies."
- No license types, pricing, entitlement, telemetry, hosting, distribution, or enforcement design introduced — directional only, no present implementation commitment. No contradiction with architecture (OANDA/broker external dependencies and broker-authority boundaries intact).

### 3. Customer-controlled / local-first (not offline-only, not SaaS) — PASS
- `vision.md:13` hardened from "Not **initially** multi-user SaaS" to "**Not multi-user SaaS**: the current scope is a single-trader, customer-controlled workstation, not a hosted service." SaaS cannot be read as current scope.
- "customer's control" wording does not promise offline-only; external broker/market-data integrations remain dependencies (`vision.md:5`). Target User retains single independent trader.
- `roadmap.md:67` deferred "multi-user SaaS" is untouched and remains compatible with single-user local-first.

### 4. Strategy-development principles — PASS
- Strategy First, Same Methodology Everywhere, Immutable Evidence, Centralized Risk, Completed Data Only all preserved verbatim in `product-principles.md`. `vision.md` Strategy First (same-StrategyVersion continuity) retained. No new Strategy framework introduced.

### 5. Safety-independent licensing boundary — PASS
- One concise principle added in `product-principles.md` ("Safety-Independent Licensing Boundary"): any future licensing/commercial mechanism stays outside the capital-safety path and must never weaken correctness, fail-closed behavior, broker-hosted protection, reconciliation, exposure visibility, or safe risk-reducing actions. Explicitly "future boundary only; it creates no current implementation task."
- Safety language is unconditional and cannot be read to weaken protection/reconciliation/fail-closed behavior/exposure visibility/risk-reducing actions (diff confirms protection + reconciliation + risk reduction all enumerated and preserved).

### 6. Scope / no roadmap expansion / no SaaS or commercial infrastructure — PASS
- No application code, roadmap, licensing/SaaS/multi-tenancy/billing/installers/cloud infrastructure/SDK packaging/Phase-6 commercial work introduced (scope boundary above + diff).
- `roadmap.md` fully unchanged (status empty); deferred list, phases, Golden Path, exit criteria intact.
- `vision.md` "Out of Scope" still lists multi-user SaaS (line 25); Product Character still "not generic SaaS dashboard" (line 29).

### 7. Direct-reference pattern — PASS
- One authoritative owner per decision: `vision.md` owns lifecycle + commercial/local-first direction; `product-principles.md` owns behavioral principles (links lifecycle); `architecture.md` uses a relative link only.
- Relative links resolve: `context/product/vision.md` (target from product-principles) and `context/architecture/../product/vision.md` (target from architecture) both exist (`ls -la` verified, same 2889-byte file).
- `architecture.md:5` retains the architectural consequence "The same StrategyVersion should move through Experiment → PAPER → LIVE without changing its trading methodology."

### 8. Contradictions — PASS (none introduced)
- No legacy lifecycle terminology remains; canonical terminology preserved. Grep across `context/product` + `context/architecture/architecture.md` for `Backtest|BacktestRun|PaperBot|LiveBot|StrategyInstance` returns **no matches**; `Experiment`, `StrategyVersion`, `PAPER`, `LIVE`, `Deployment`, `Risk` capitalization/meanings intact.
- No duplicated long-form vision remains; no statement conflicts with `AGENTS.md` invariants (all safety rules unconditional) or roadmap authority.
- No audit findings, commercial design, roadmap acceptance, or new implementation tasks introduced.

## Result

**PASS** — all PLAN acceptance criteria met (one authoritative home per decision; lifecycle/proprietary/licensed/customer-controlled/Strategy-principles/safety-independent-licensing-boundary clear; no scope expansion; no contradictory or duplicated long-form vision). Direct-reference pattern correct. Changes are documentation-only and confined to the three prescribed context files.

## Reusable receipts

- Legacy lifecycle absent: grep `Build.*Test.*Deploy|test.*deploy|Test.*Deploy` in `context/` → only `architecture.md:21` backend-stack sentence (not lifecycle).
- Canonical lifecycle homes: `context/product/vision.md` (lines 5, 37); `product-principles.md:5` (direct link); architecture restates none.
- Boundary evidence: `git status --porcelain context/roadmap/roadmap.md` empty; `context/features/*` absent from modified list.
- Link resolution: both `context/product/vision.md` and `context/architecture/../product/vision.md` exist.
- Terminology: no `Backtest|BacktestRun|PaperBot|LiveBot|StrategyInstance` in `context/product` or `context/architecture/architecture.md`.

## Readiness

Workstream remains at `dispatch/workstreams/product-vision-alignment/` on branch `feature/product-vision-alignment`; changes preserved. Next transition per PLAN: Documentation review (`REVIEW.md`). No Git commit, push, merge, reset, or branch deletion performed.
